查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750794

数位病理学市场规模、份额、趋势分析报告：按产品、类型、应用、最终用途、地区、细分市场预测，2025-2030 年

Digital Pathology Market Size, Share & Trends Analysis Report By Product (Software, Device), By Type, By Application (Academic Research, Disease Diagnosis), By End Use (Diagnostic Labs, Hospitals), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 185 Pages | 商品交期: 2-10个工作天内

价格

数位病理学市场的成长和趋势：

根据 Grand View Research, Inc. 的一份新报告，预计到 2030 年全球数位病理学市场规模将达到 17.4 亿美元。

预计2025年至2030年期间，该市场的复合年增长率将达到8.2%。由于慢性病盛行率的上升以及对精准诊断的需求不断增长，预计市场将呈指数级增长。慢性病影响近三分之一的美国成年人。根据美国疾病管制与预防中心的数据，约51.8%的美国成年人至少患有一种慢性病。数位病理学涵盖分子组织分析、生物样本库、组织微阵列分析和分子生物学，在药物开发平臺和伴随诊断中发挥关键作用。组织生物标记研究中对高品质组织样本的需求不断增长，预计将在预测期内推动该技术的普及。

随着远端病理学技术的不断更新，其应用范围正在不断扩大。例如，Tribun Health 于 2022 年 6 月推出了 TeleSlide Patho 5，这是一个线上远距病理学平台，用于为患者提供临床和及时的专业知识。此外，随着各公司采取更严格的竞争策略，预计在不久的将来，远距病理学市场将面临激烈的竞争。此外，病理实验室数位化等技术进步正在提高该专业的效率，提高检体的可重复性，并减轻病理学家的工作负担。过去几年，多项突破性进展显着推动了市场的成长。

例如，2021年9月，Paige的前列腺癌检测人工智慧解决方案Paige Prostate获得FDA核准，这是第一个获得上市核准的人工智慧病理学产品。 2021年10月，罗氏公司（F. Hoffmann-La Roche Ltd.）与Ibex合作开发基于人工智慧的病理学应用程序，旨在改善患者照护。此外，主要企业正在采取合作与伙伴关係等策略，重点关注机器人光学显微镜、数影像处理、多光纤通讯和电脑化等技术进步，以加强数位病理学的普及。

例如，Deciphex 于 2022 年 12 月推出了 Patholytix 3.0，这是一个数位研究病理学平台，旨在彻底改变病理学家可用的工具，并克服 LIMS 软体的局限性，使用户能够有效地管理相关数据和样本。此外，该公司还宣布了新平台的一些功能，这些功能将影响工作流程，并使报告更简单、更快捷。

数位病理市场报告重点

  • 按产品划分，预计到2024年，设备细分市场将占据最大份额，达到51.50%，并预计在预测期内将保持可观的成长率。设备细分市场包括切片管理系统和扫描器。该细分市场的成长可归因于数位病理学在学术研究活动中的日益普及，其分辨率也得到了提升。
  • 从应用角度来看，由于慢性病盛行率上升和对先进诊断技术的需求不断增加，疾病诊断预计将在 2025 年至 2030 年间实现最快的成长率。
  • 根据最终用途，由于医疗保健环境中越来越多地采用数位病理诊断来实现高效的疾病诊断，医院部门将在 2024 年占据市场主导地位，占有 36.7% 的份额。
  • 由于拥有完善的数位基础设施以及医疗保健环境中采用技术的多项技术进步，北美在 2024 年占据了整个市场的 40.10% 的份额。

目录

第一章调查方法与范围

第二章执行摘要

第三章数字病理学市场变数、趋势和范围

  • 数位病理市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业挑战
    • 机会分析
  • 数位病理学市场分析工具：波特五力分析
  • SWOT分析：依因素（政治/法律、经济、社会、科技）
    • 科技趋势分析
  • 法律规范
    • 对新参与者的监管要求
    • 政治局势、当前情势和未来情势
  • 成本结构分析
    • 实施成本
    • 价格下降分析
  • 使用者观点分析
    • 消费行为分析
  • 案例研究
  • COVID-19的影响
    • 打入市场策略

第四章数位病理学市场：产品估计与趋势分析

  • 数位病理学市场：产品亮点
  • 数位病理市场：产品趋势分析
  • 软体
  • 装置
    • 扫描器
    • 幻灯片管理系统
  • 储存系统

第五章数位病理学市场：应用评估与趋势分析

  • 数位病理市场：关键应用点
  • 数位病理市场：应用变化分析
  • 药物研发
  • 学术研究
  • 疾病诊断
    • 癌细胞检测
    • 其他的

第六章数字病理学市场：类型估计和趋势分析

  • 数位病理市场：类型要点
  • 数位病理学市场：类型变化分析
  • 人体病理学
  • 兽医病理学

第七章数字病理学市场：最终用途估计和趋势分析

  • 数位病理学市场：关键最终用途点
  • 数位病理学市场：最终用途趋势分析
  • 医院
  • 生物技术和製药公司
  • 诊断实验室
  • 学术和研究机构

第 8 章数位病理学市场：区域估计和趋势分析（按产品、应用和最终用途）

  • 数位病理学市场：区域趋势分析
  • 2023 年及 2030 年各地区数位病理学市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 荷兰
    • 瑞士
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 印尼
    • 泰国
    • 澳洲
    • 韩国
    • 菲律宾
    • 马来西亚
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 土耳其
    • 伊朗
    • 阿拉伯聯合大公国
    • 以色列
    • 科威特

第九章数位病理学市场竞争与供应商格局

  • 参与类别
  • 供应商格局
    • 经销商名单
  • 企业市场分析
    • 上市公司
    • 私人公司
  • 2024年公司市场占有率评估分析（%）
  • 公司简介
    • Leica Biosystems Nussloch Gmbh (Danaher)
    • HAMAMATSU PHOTONICS KK
    • KONINKLIJKE PHILIPS NV
    • OLYMPUS CORPORATION
    • MIKROSCAN TECHNOLOGIES, INC.
    • INSPIRATA, INC.
    • VISIOPHARM A/S
    • HURON TECHNOLOGIES INTERNATIONAL, INC.
    • 3DHISTECH LTD.
    • CONTEXTVISION AB
    • SECTRA AB
    • AGFA-GEVAERT GROUP
    • 细胞视觉
    • HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
    • WEST MEDICA PRODUKTIONS- UND HANDELS- GMBH (WEST MEDICA)
    • AETHERAI
    • IBEX (IBEX MEDICAL ANALYTICS)
    • SIGTUPLE TECHNOLOGIES PRIVATE LIMITED
    • MORPHLE LABS, INC
    • BIONOVATION BIOTECH, INC
    • SCOPIO LABS
    • PATH HUB US
    • F. HOFFMANN-LA ROCHE LTD.
    • Aiosyn
    • Proscia Inc
    • EVIDENT
    • Aignostics, Inc.
    • AIRA MATRIX
    • Deep Bio Inc.
    • Indica Labs, LLC
    • Paige AI
    • PathAI, Inc.
    • Aiforia
    • Dedalus SpA
    • Qritive
    • Mindpeak GmbH
    • CGI Inc.
    • Gestalt
    • Epredia (3DHISTECH Ltd.)
Product Code: 978-1-68038-386-7

Digital Pathology Market Growth & Trends:

The global digital pathology market size is anticipated to reach USD 1.74 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.2% from 2025 to 2030. The market is anticipated to witness exponential growth owing to rising prevalence of chronic diseases aided by increasing demand for accurate diagnostics. Chronic diseases affect nearly one in every three adults. Whereas, according to the CDC, in the U.S., approximately, 51.8% of adults have at least one chronic disease. Digital pathology, including molecular tissue profiling, biobanking, tissue microarray analysis, and molecular biology, plays an important role in the drug development pipeline and companion diagnostics. Growing demand for high-quality tissue samples in tissue-based biomarker research is expected to drive technology adoption over the forecast period.

Increasing adoption of telepathology with the launch of newer versions of the technology, such as in June 2022, Tribun Health launched TeleSlide Patho 5, an online telepathology platform used for providing clinical and timely expertise to patients. Moreover, the market is expected to see intense competition in the near future as companies adopt more stringent strategies to compete. Moreover, technological advancements, such as the digitization of pathology lab makes the specialty more efficient, the specimen more reproducible, and pathologists' work easier. In past few years, several breakthrough advancements have provided a significant boost to market growth.

For instance, in September 2021, Paige received FDA approval for Paige Prostate, an AI solution for the detection of prostate cancer. The product is the first AI-enabled pathology product to gain marketing authorization. This was further followed by the collaboration of F. Hoffmann-La Roche Ltd. with Ibex in October 2021 for the development of artificial intelligence-based pathology applications for the improvement of patient care. Furthermore, major players are adopting strategies like collaborations and partnerships with a focus on technological advancements, such as robotic light microscopy, digital imaging, multiple fiber optic communications, and computerization, to enhance the adoption of digital pathology.

For instance, in December 2022, Deciphex launched Patholytix 3.0, a Digital Research Pathology Platform with an aim to revolutionize tools available for research pathologists and designed to overcome the limits of LIMS software that allows users to effectively manage associated data and samples. Furthermore, with the launch, the company also highlighted features of the new platform that impact workflow and offer simpler and more expedient report creation.

Digital Pathology Market Report Highlights:

  • Based on product, The device segment held the largest share of 51.50% in 2024 and is anticipated to grow at a lucrative growth rate during the projected period. The device segment includes a slide management system and scanner. The segment growth is attributed to the increasing adoption of digital pathology in academic research activities with enhanced resolution
  • Based on application, Disease diagnosis is anticipated to witness the fastest growth rate from 2025 to 2030 due to an increasing prevalence of chronic diseases and demand for noble diagnosis techniques
  • In terms of end-use, The hospitals segment dominated the market in 2024 with a share of 36.7% due to the growing incorporation of digital pathologies in healthcare settings for efficient disease diagnosis
  • North America dominated overall market in 2024 with a share of 40.10%, due to the presence of well-established digital infrastructure and several technological advancements pertaining to the incorporation of technology in healthcare settings

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
  • 1.4 Model Details
    • 1.4.1 Commodity Workflow Analysis (Model 1)
    • 1.4.2 Volume Price Analysis (Model 2)
    • 1.4.3 Market Survey Research Methodology
      • 1.4.3.1 General Methodology
    • 1.4.4 Country Level Assumptions
    • 1.4.5 Subsegment Level Assumptions
  • 1.5 List of Primary Sources
  • 1.6 List of Secondary Sources
  • 1.7 List of Abbreviations
  • 1.8 Market Definitions
  • 1.9 Report Objectives

Chapter 2 Executive Summary

  • 2.1 Digital Pathology Market Snapshot
    • 2.1.1 Digital Pathology Market Snapshot: Type & Product Segment Outlook
    • 2.1.2 Digital Pathology Market Snapshot: Application & End Use Segment Outlook
    • 2.1.3 Digital Pathology Market Snapshot: Competitive Outlook

Chapter 3 Digital Pathology Market Variables, Trends and Scope

  • 3.1 Digital Pathology Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Increasing prevalence of chronic diseases
      • 3.1.1.2 Higher cost-efficiency
      • 3.1.1.3 Rapid technological advancements in the overall digital pathology market
        • 3.1.1.3.1 Competitive Factors and Strategies
          • 3.1.1.3.1.1 List of Top Notable Funded Digital Pathology Companies, By Countries
          • 3.1.1.3.1.2 Top 10 Vendor - by Total Funding from 2014 - 2021 (Potential vendors for collabrations)
      • 3.1.1.4 Increasing demand for integrated healthcare systems and patient-centric care-
      • 3.1.1.5 Growing adoption of digital pathology solutions in veterinary care practices
      • 3.1.1.6 Rapid technological advancements in digital pathology solutions in veterinary field
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Lack of skilled professionals
      • 3.1.2.2 High cost of implementing digital pathology solutions
        • 3.1.2.2.1 Digital Pathology Expenses
    • 3.1.3 Industry Challenges
      • 3.1.3.1 Lack of reimbursement for digital pathology-enabled services
      • 3.1.3.2 Data security and privacy
    • 3.1.4 Opportunity Analysis
      • 3.1.4.1 Potential growth for digital pathology solutions
  • 3.2 Digital Pathology Market Analysis Tools: Porters
  • 3.3 SWOT Analysis by Factors (Political & Legal, Economic, Social, and Technology)
    • 3.3.1 Technology Trend Analysis
      • 3.3.1.1 Digitization in Pathology Labs
  • 3.4 Regulatory Framework
    • 3.4.1 Regulatory Requirements For New Players
      • 3.4.1.1 Food and Drug Administration (FDA)
      • 3.4.1.2 Centers for Medicare and Medicaid Services (CMS)/Clinical Laboratory Improvement Amendments (CLIA)
      • 3.4.1.3 College of American Pathologists (CAP)
    • 3.4.2 Political Landscape, Current & Future Scenario
  • 3.5 Cost Structure Analysis
    • 3.5.1 Cost Of Implementation
      • 3.5.1.1 Secondary Research Analysis on digital pathology operational costs
    • 3.5.2 Price Erosion Analysis
  • 3.6 User Perspective Analysis
    • 3.6.1 Consumer Behaviour Analysis
      • 3.6.1.1 Consumer Preference
  • 3.7 Case Study
  • 3.8 Covid-19 Impact
    • 3.8.1 Market Entry Strategies
      • 3.8.1.1 Competitive Strategies

Chapter 4 Digital Pathology Market: Product Estimates & Trend Analysis

  • 4.1 Digital Pathology Market: Product Key Takeaways
  • 4.2 Digital Pathology Market: Product Movement Analysis
  • 4.3 Software
    • 4.3.1 Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.4 Device
    • 4.4.1 Device Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2 Scanners
      • 4.4.2.1 Scanners Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.3 Slide Management System
      • 4.4.3.1 Slide Management System Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.5 Storage System
    • 4.5.1 Storage System Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5 Digital Pathology Market: Application Estimates & Trend Analysis

  • 5.1 Digital Pathology Market: Application Key Takeaways
  • 5.2 Digital Pathology Market: Application Movement Analysis
  • 5.3 Drug Discovery & Development
    • 5.3.1 Drug Discovery & Development Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.4 Academic Research
    • 5.4.1 Academic Research Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.5 Disease Diagnosis
    • 5.5.1 Disease Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.2 Cancer Cell Detection
      • 5.5.2.1 Cancer Cell Detection Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.3 Others
      • 5.5.3.1 Others market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 6 Digital Pathology Market: Type Estimates & Trend Analysis

  • 6.1 Digital Pathology Market: Type Key Takeaways
  • 6.2 Digital Pathology Market: Type Movement Analysis
  • 6.3 Human Pathology
    • 6.3.1 Human Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.4 Veterinary Pathology
    • 6.4.1 Veterinary Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7 Digital Pathology Market: End-use Estimates & Trend Analysis

  • 7.1 Digital Pathology Market: End-Use Key Takeaways
  • 7.2 Digital Pathology Market: End-Use Movement Analysis
  • 7.3 Hospitals
    • 7.3.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.4 Biotechnology & Pharmaceutical Companies
    • 7.4.1 Biotechnology & Pharmaceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.5 Diagnostic Laboratories
    • 7.5.1 Diagnostic Laboratories Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.6 Academic And Research Institutes
    • 7.6.1 Academic And Research Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 8 Digital Pathology Market: Regional Estimates & Trend Analysis, by Product, Application, End Use

  • 8.1 Digital Pathology Market: Region Movement Analysis
  • 8.2 Digital Pathology Market Shares by Region, 2023 & 2030
  • 8.3 North America
    • 8.3.1 North America Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.2 U.S.
      • 8.3.2.1 U.S. digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.3.3 Canada
      • 8.3.3.1 Canada digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.3.4 Mexico
      • 8.3.3.1 Canada digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4 Europe
    • 8.4.1 Europe Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.3 UK
      • 8.4.3.1 UK digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.4 Germany
      • 8.4.4.1 Germany digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.5 France
      • 8.4.5.1 France digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.6 Italy
      • 8.4.6.1 Italy digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.7 Spain
      • 8.4.7.1 Spain digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.8 Russia
      • 8.4.8.1 Russia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.9 Netherlands
      • 8.4.9.1 Netherlands digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.10 Switzerland
      • 8.4.10.1 Switzerland digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.11 Sweden
      • 8.4.11.1 Sweden digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.12 Denmark
      • 8.4.12.1 Denmark digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.13 Norway
      • 8.4.13.1 Norway digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.5 Asia Pacific
    • 8.5.1 Asia Pacific Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.2 Japan
      • 8.5.2.1 Japan digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.3 China
      • 8.5.3.1 China digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.4 India
      • 8.5.4.1 India digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.5 Indonesia
      • 8.5.5.1 Indonesia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.6 Thailand
      • 8.5.6.1 Thailand digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.7 Australia
      • 8.5.7.1 Australia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.8 South Korea
      • 8.5.8.1 South Korea digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.9 Philippines
      • 8.5.9.1 Philippines digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.11 Malaysia
      • 8.5.11.1 Malaysia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.12 Singapore
      • 8.5.12.1 Singapore digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.6 Latin America
    • 8.6.1 Latin America Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.3 Brazil
      • 8.6.3.1 Brazil digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.6.4 Argentina
      • 8.6.4.1 Argentina digital pathology market estimates and forecasts, 2018- 2030 (USD Billion)
  • 8.7 MEA
    • 8.7.1 Mea Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 8.7.2 South Africa
      • 8.7.2.1 South Africa digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.3 Saudi Arabia
      • 8.7.3.1 Saudi arabia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.4 Turkey
      • 8.7.4.1 Turkey digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.5 Iran
      • 8.7.5.1 Iran digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.6 UAE
      • 8.7.6.1 UAE digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.7 Israel
      • 8.7.7.1 Israel digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.8 Kuwait
      • 8.7.8.1 Kuwait digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 9 Digital Pathology Market Competitive & Vendor Landscape

  • 9.1 Participation Categorization
  • 9.2 Vendor Landscape
    • 9.2.1 List Of Distributors
  • 9.3 Company Market Position Analysis
    • 9.3.1 Public Companies
    • 9.3.2 Private Companies
  • 9.4 Estimated Company Market Share Analysis, 2024 (%)
  • 9.5 Company Profiles
    • 9.5.1 Leica Biosystems Nussloch Gmbh (Danaher)
      • 9.5.1.1 Company overview
      • 9.5.1.2 Financial performance
      • 9.5.1.3 Product benchmarking
        • 9.5.1.3.1 Human DIgital Pathology
      • 9.5.1.4 Strategic initiatives
    • 9.5.2 HAMAMATSU PHOTONICS K.K.
      • 9.5.2.1 Company overview
      • 9.5.2.2 Financial performance
      • 9.5.2.3 Product benchmarking
        • 9.5.2.3.1 Human DIgital Pathology
      • 9.5.2.4 Strategic initiatives
    • 9.5.3 KONINKLIJKE PHILIPS N.V.
      • 9.5.3.1 Company overview
      • 9.5.3.2 Financial performance
      • 9.5.3.3 Product benchmarking
        • 9.5.3.3.1 Human DIgital Pathology
      • 9.5.3.4 Strategic initiatives
    • 9.5.4 OLYMPUS CORPORATION
      • 9.5.4.1 Company overview
      • 9.5.4.2 Financial performance
      • 9.5.4.3 Product benchmarking
        • 9.5.4.3.1 Human DIgital Pathology
      • 9.5.4.4 Strategic initiatives
      • 9.5.4.5 Company overview
      • 9.5.4.6 Financial performance
      • 9.5.4.7 Product benchmarking
        • 9.5.4.7.1 Human DIgital Pathology
      • 9.5.4.8 Strategic initiatives
    • 9.5.5 MIKROSCAN TECHNOLOGIES, INC.
      • 9.5.5.1 Company overview
      • 9.5.5.2 Financial performance
      • 9.5.5.3 Product benchmarking
        • 9.5.5.3.1 Human DIgital Pathology
      • 9.5.5.4 Strategic initiatives
    • 9.5.6 INSPIRATA, INC.
      • 9.5.6.1 Company overview
      • 9.5.6.2 Financial performance
      • 9.5.6.3 Product benchmarking
        • 9.5.6.3.1 Human DIgital Pathology
      • 9.5.6.4 Strategic initiatives
    • 9.5.7 VISIOPHARM A/S
      • 9.5.7.1 Company overview
      • 9.5.7.2 Financial performance
      • 9.5.7.3 Product benchmarking
        • 9.5.7.3.1 Human DIgital Pathology
      • 9.5.7.4 Strategic initiatives
    • 9.5.8 HURON TECHNOLOGIES INTERNATIONAL, INC.
      • 9.5.8.1 Company overview
      • 9.5.8.2 Financial performance
      • 9.5.8.3 Product benchmarking
        • 9.5.8.3.1 Human DIgital Pathology
      • 9.5.8.4 Strategic initiatives
    • 9.5.9 3DHISTECH LTD.
      • 9.5.9.1 Company overview
      • 9.5.9.2 Financial performance
      • 9.5.9.3 Product benchmarking
        • 9.5.9.3.1 Human DIgital Pathology
        • 9.5.9.3.2 Veterinary DIgital Pathology
      • 9.5.9.4 Strategic initiatives
    • 9.5.10 CONTEXTVISION AB
      • 9.5.10.1 Company overview
      • 9.5.10.2 Financial performance
      • 9.5.10.3 Product benchmarking
        • 9.5.10.3.1 Human DIgital Pathology
      • 9.5.10.4 Strategic initiatives
    • 9.5.11 SECTRA AB
      • 9.5.11.1 Company overview
      • 9.5.11.2 Financial Performance
      • 9.5.11.3 Product benchmarking
        • 9.5.11.3.1 Human DIgital Pathology
      • 9.5.11.4 Strategic initiatives
    • 9.5.12 AGFA-GEVAERT GROUP
      • 9.5.12.1 Company overview
      • 9.5.12.2 Financial Performance
      • 9.5.12.3 Product benchmarkin
        • 9.5.12.3.1 Human DIgital Pathology
      • 9.5.12.4 Strategic initiatives
    • 9.5.13 CELLAVISION
      • 9.5.13.1 Company overview
      • 9.5.13.2 Financial performance
      • 9.5.13.3 Product benchmarking
        • 9.5.13.3.1 Veterinary DIgital Pathology
      • 9.5.13.4 Strategic initiatives
    • 9.5.14 HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
      • 9.5.14.1 Company overview
      • 9.5.14.2 Financial performance
      • 9.5.14.3 Product benchmarking
        • 9.5.14.3.1 Human DIgital Pathology
    • 9.5.15 WEST MEDICA PRODUKTIONS- UND HANDELS- GMBH (WEST MEDICA)
      • 9.5.15.1 Company overview
      • 9.5.15.2 Financial performance
      • 9.5.15.3 Product benchmarking
        • 9.5.15.3.1 Human DIgital Pathology
        • 9.5.15.3.2 Veterinary DIgital Pathology
    • 9.5.16 AETHERAI
      • 9.5.16.1 Company overview
      • 9.5.16.2 Financial performance
      • 9.5.16.3 Product benchmarking
        • 9.5.16.3.1 Human DIgital Pathology
      • 9.5.16.4 Strategic initiatives
    • 9.5.17 IBEX (IBEX MEDICAL ANALYTICS)
      • 9.5.17.1 Company overview
      • 9.5.17.2 Financial performance
      • 9.5.17.3 Product benchmarking
        • 9.5.17.3.1 Human DIgital Pathology
      • 9.5.17.4 Strategic initiatives
    • 9.5.18 SIGTUPLE TECHNOLOGIES PRIVATE LIMITED
      • 9.5.18.1 Company overview
      • 9.5.18.2 Financial performance
      • 9.5.18.3 Product benchmarking
        • 9.5.18.3.1 Human DIgital Pathology
      • 9.5.18.4 Strategic initiatives
    • 9.5.19 MORPHLE LABS, INC
      • 9.5.19.1 Company overview
      • 9.5.19.2 Financial performance
      • 9.5.19.3 Product benchmarking
        • 9.5.19.3.1 Human DIgital Pathology
      • 9.5.19.4 Strategic initiatives
    • 9.5.20 BIONOVATION BIOTECH, INC
      • 9.5.20.1 Company overview
      • 9.5.20.2 Financial performance
      • 9.5.20.3 Product benchmarking
        • 9.5.20.3.1 Human DIgital Pathology
    • 9.5.21 SCOPIO LABS
      • 9.5.21.1 Company overview
      • 9.5.21.2 Financial performance
      • 9.5.21.3 Product benchmarking
        • 9.5.21.3.1 Veterinary DIgital Pathology
      • 9.5.21.4 Strategic initiatives
    • 9.5.22 PATH HUB US
      • 9.5.22.1 Company overview
      • 9.5.22.2 Product benchmarking
        • 9.5.22.2.1 Human Digital Pathology
        • 9.5.22.2.2 Veterinary Digital Pathology
    • 9.5.23. F. HOFFMANN-LA ROCHE LTD.
      • 9.5.23.1. Overview
      • 9.5.23.2. Financial Performance
      • 9.5.23.3. Product Benchmarking
      • 9.5.23.4. Strategic Initiatives
    • 9.5.24. Aiosyn
      • 9.5.24.1. Overview
      • 9.5.24.2. Financial Performance
      • 9.5.24.3. Product Benchmarking
      • 9.5.24.4. Strategic Initiatives
    • 9.5.25. Proscia Inc
      • 9.5.25.1. Overview
      • 9.5.25.2. Financial Performance
      • 9.5.25.3. Product Benchmarking
      • 9.5.25.4. Strategic Initiatives
    • 9.5.26. EVIDENT
      • 9.5.26.1. Overview
      • 9.5.26.2. Financial Performance
      • 9.5.26.3. Product Benchmarking
      • 9.5.26.4. Strategic Initiatives
    • 9.5.27. Aignostics, Inc.
      • 9.5.27.1. Overview
      • 9.5.27.2. Financial Performance
      • 9.5.27.3. Product Benchmarking
      • 9.5.27.4. Strategic Initiatives
    • 9.5.28. AIRA MATRIX
      • 9.5.28.1. Overview
      • 9.5.28.2. Financial Performance
      • 9.5.28.3. Product Benchmarking
      • 9.5.28.4. Strategic Initiatives
    • 9.5.29. Deep Bio Inc.
      • 9.5.29.1. Overview
      • 9.5.29.2. Financial Performance
      • 9.5.29.3. Product Benchmarking
      • 9.5.29.4. Strategic Initiatives
    • 9.5.30. Indica Labs, LLC
      • 9.5.30.1. Overview
      • 9.5.30.2. Financial Performance
      • 9.5.30.3. Product Benchmarking
      • 9.5.30.4. Strategic Initiatives
    • 9.5.31. Paige AI
      • 9.5.31.1. Overview
      • 9.5.31.2. Financial Performance
      • 9.5.31.3. Product Benchmarking
      • 9.5.31.4. Strategic Initiatives
    • 9.5.32. PathAI, Inc.
      • 9.5.32.1. Overview
      • 9.5.32.2. Financial Performance
      • 9.5.32.3. Product Benchmarking
      • 9.5.32.4. Strategic Initiatives
    • 9.5.33. Aiforia
      • 9.5.33.1. Overview
      • 9.5.33.2. Financial Performance
      • 9.5.33.3. Product Benchmarking
      • 9.5.33.4. Strategic Initiatives
    • 9.5.34. Dedalus S.p.A
      • 9.5.34.1. Overview
      • 9.5.34.2. Financial Performance
      • 9.5.34.3. Product Benchmarking
      • 9.5.34.4. Strategic Initiatives
    • 9.5.35. Qritive
      • 9.5.35.1. Overview
      • 9.5.35.2. Financial Performance
      • 9.5.35.3. Product Benchmarking
      • 9.5.35.4. Strategic Initiatives
    • 9.5.36. Mindpeak GmbH
      • 9.5.36.1. Overview
      • 9.5.36.2. Financial Performance
      • 9.5.36.3. Product Benchmarking
      • 9.5.36.4. Strategic Initiatives
    • 9.5.37. CGI Inc.
      • 9.5.37.1. Overview
      • 9.5.37.2. Financial Performance
      • 9.5.37.3. Product Benchmarking
      • 9.5.37.4. Strategic Initiatives
    • 9.5.38. Gestalt
      • 9.5.38.1. Overview
      • 9.5.38.2. Financial Performance
      • 9.5.38.3. Product Benchmarking
      • 9.5.38.4. Strategic Initiatives
    • 9.5.39 Epredia (3DHISTECH Ltd.)
      • 9.5.39.1. Overview
      • 9.5.39.2. Financial Performance
      • 9.5.39.3. Product Benchmarking
      • 9.5.39.4. Strategic Initiatives
f

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Digital Pathology Market, By Country, 2018 - 2030 (USD Billion)
  • Table 4 North America Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 5 North America Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 6 North America Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 7 North America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 8 U.S. Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 9 U.S. Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 10 U.S. Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 11 U.S. Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 12 Canada Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 13 Canada Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 14 Canada Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 15 Canada Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 16 Mexico Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 17 Mexico Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 18 Mexico Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 19 Mexico Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 20 Europe Digital Pathology Market, By Country, 2018 - 2030 (USD Billion)
  • Table 21 Europe Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 22 Europe Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 23 Europe Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 24 Europe Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 25 UK Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 26 UK Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 27 UK Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 28 UK Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 29 Germany Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 30 Germany Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 31 Germany Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 32 Germany Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 33 France Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 34 France Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 35 France Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 36 France Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 37 Italy Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 38 Italy Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 39 Italy Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 40 Italy Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 41 Spain Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 42 Spain Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 43 Spain Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 44 Spain Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 45 Russia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 46 Russia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 47 Russia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 48 Russia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 49 Switzerland Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 50 Switzerland Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 51 Switzerland Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 52 Switzerland Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 53 Netherlands Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 54 Netherlands Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 55 Netherlands Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 56 Netherlands Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 57 Denmark Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 58 Denmark Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 59 Denmark Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 60 Denmark Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 61 Norway Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 62 Norway Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 63 Norway Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 64 Norway Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 65 Sweden Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 66 Sweden Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 67 Sweden Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 68 Sweden Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 69 Asia Pacific Digital Pathology Market, By Country, 2018 - 2030 (USD Billion)
  • Table 70 Asia Pacific Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 71 Asia Pacific Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 72 Asia Pacific Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 73 Asia Pacific Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 74 Japan Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 75 Japan Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 76 Japan Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 77 Japan Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 78 China Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 79 China Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 80 China Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 81 China Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 82 India Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 83 India Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 84 India Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 85 India Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 86 Indonesia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 87 Indonesia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 88 Indonesia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 89 Indonesia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 90 Thailand Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 91 Thailand Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 92 Thailand Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 93 Thailand Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 94 Australia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 95 Australia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 96 Australia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 97 Australia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 98 South Korea Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 99 South Korea Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 100 South Korea Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 101 South Korea Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 102 Philippines Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 103 Philippines Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 104 Philippines Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 105 Philippines Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 106 Malaysia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 107 Malaysia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 108 Malaysia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 109 Malaysia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 110 Singapore Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 111 Singapore Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 112 Singapore Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 113 Singapore Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 114 Latin America Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 115 Latin America Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 116 Latin America Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 117 Latin America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 118 Brazil Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 119 Brazil Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 120 Brazil Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 121 Brazil Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 122 Argentina Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 123 Argentina Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 124 Argentina Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 125 Argentina Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 126 MEA Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 127 MEA Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 128 MEA Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 129 MEA Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 130 South Africa Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 131 South Africa Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 132 South Africa Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 133 South Africa Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 134 Saudi Arabia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 135 Saudi Arabia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 136 Saudi Arabia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 137 Saudi Arabia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 138 Turkey Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 139 Turkey Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 140 Turkey Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 141 Turkey Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 142 Iran Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 143 Iran Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 144 Iran Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 145 Iran Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 146 UAE Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 147 UAE Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 148 UAE Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 149 UAE Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 150 Israel Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 151 Israel Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 152 Israel Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 153 Israel Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 154 Kuwait Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 155 Kuwait Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 156 Kuwait Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 157 Kuwait Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Digital pathology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Digital pathology market: Product movement analysis
  • Fig. 17 Digital pathology market: Product segment dashboard
  • Fig. 18 Digital pathology market product outlook: Key takeaways
  • Fig. 19 Software market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Integrated Software market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Standalone Software market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Device market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Storage system market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Digital pathology market: Type movement analysis
  • Fig. 25 Digital pathology market: Type segment dashboard
  • Fig. 26 Digital pathology market type outlook: Key takeaways
  • Fig. 27 Human digital pathology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Veterinary digital pathology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Digital pathology market: Application movement analysis
  • Fig. 30 Digital pathology market: Application segment dashboard
  • Fig. 31 Digital pathology market application outlook: Key takeaways
  • Fig. 32 Drug discovery & development market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Academic research market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Disease diagnosis market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Digital pathology market: End-use movement analysis
  • Fig. 36 Digital pathology market: End-use segment dashboard
  • Fig. 37 Digital pathology market end-use outlook: Key takeaways
  • Fig. 38 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 39 Biotech & pharma companies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Academic &research institutes market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Regional outlook, 2023 & 2030
  • Fig. 43 Regional market dashboard
  • Fig. 44 Regional market place: Key takeaways
  • Fig. 45 North America, SWOT
  • Fig. 46 Europe, SWOT
  • Fig. 47 Asia Pacific, SWOT
  • Fig. 48 Latin America, SWOT
  • Fig. 49 Middle East and Africa, SWOT
  • Fig. 50 North America
  • Fig. 51 North America Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 52 U.S. Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 53 Canada Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 54 Mexico Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 55 Europe Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 56 UK Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 57 Germany Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 58 Spain Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 59 France Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 60 Italy Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 61 Russia Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 62 Ntherlands Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 63 Switzerland Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 64 Denmark Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 65 Norway Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 66 Sweden Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 67 Asia Pacific Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 68 Japan Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 69 China Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 70 India Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 71 South Korea Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 72 Australia Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 73 Thailand Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 74 Indonasia Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 75 South Korea Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 76 Philippines Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 77 Malaysia Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 78 Singapore Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 79 Latin America Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 80 Brazil Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 81 Argentina Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 82 MEA Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 83 South Africa Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 84 Saudi Arabia Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 85 Turkey Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 86 Iran Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 87 Italy Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 88 UAE Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 89 Isarel Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 90 Kuwait Digital pathology market, 2018 - 2030 (USD Billion)